A Study of ASN007 in Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
2020-06-30
Target enrollment:
Participant gender:
Summary
The study is divided into two parts. The first part of the study will test various doses of
ASN007 to find out the highest safe dose to test in five specific groups. The second part of
the study will test how well ASN007 can control cancer.